Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.21.2
Condensed Consolidated Balance Sheets - USD ($)
$ in Millions
Sep. 30, 2021
Dec. 31, 2020
Current assets:    
Cash and cash equivalents $ 722 $ 423
Accounts receivable and contract assets, net of allowance for credit losses of $32 million and $33 million, respectively 198 83
Income taxes receivable 52 50
Other current assets 28 23
Total current assets 1,000 579
Property and equipment, net 121 132
Intangible assets not subject to amortization:    
Goodwill 2,224 2,240
Trademarks 730 732
Intangible assets not subject to amortization 2,954 2,972
Intangible assets subject to amortization, net 149 202
Other assets, at cost, net of accumulated amortization 193 201
Total assets 4,417 4,086
Current liabilities:    
Deferred merchant and other payables 145 54
Deferred revenue 39 28
Accrued liabilities and other current liabilities 180 160
Total current liabilities 364 242
Long-term debt, including $276 million measured at fair value as of September 30, 2021 (note 5) 1,149 532
Deferred income tax liabilities 150 180
Financial instrument liabilities (note 4) 137 14
Preferred stock liability (note 6) 208  
Other liabilities 320 339
Total liabilities 2,328 1,307
Redeemable preferred stock, $.01 par value. Authorized shares 50,000,000; issued and outstanding 187,414 shares at September 30, 2021 and 325,000 shares at December 31, 2020 (note 6) 472
Equity:    
Additional paid-in capital 286 257
Accumulated other comprehensive earnings (loss), net of taxes (18) (23)
Retained earnings (deficit) (513) (278)
Total stockholders' equity (244) (43)
Noncontrolling interests in equity of subsidiaries 2,333 2,350
Total equity 2,089 2,307
Commitments and contingencies (note 8)
Total liabilities, redeemable preferred stock and equity 4,417 4,086
Series A    
Equity:    
Common stock value 1 1
Series B    
Equity:    
Common stock value
Series C    
Equity:    
Common stock value